Published 5 hours ago • loading... • Updated 1 day ago

Trump takes credit for prescription drug prices falling in July

President Donald Trump claimed credit for a 3.1% year-over-year decline in prescription drug prices, telling reporters at Joint Base Andrews that "prescription prices are down" as he held up a news article.
The White House credits the drop to new agreements between the administration and drug companies, plus the launch of TrumpRX, while the 2022 Inflation Reduction Act signed by former President Joe Biden now allows Medicare to negotiate lower prescription costs.
Cynthia Cox with KFF told Spectrum News the situation is "a little bit complicated," citing a combination of Republican and Democrat policies alongside market pressure. She also noted significant price drops for GLP-1s.
Richard Frank of the Brookings Institution cautioned that despite the steepest decline in over 60 years, "the really important thing here is to not interpret this as if manufactured drug prices are falling."
Experts suggest the price decline reflects an "all-of-the-above" mix of Republican and Democrat policies, market pressure, and Biden-era initiatives, indicating that sustained reductions depend on continued implementation across administrations.

Insights by Ground AI